Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06635668 · ClinicalTrials.gov registry record
Baseline ACL Injury Risk Screening and Normative Data
A clinical trial of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, sponsored by Sanford Health.
- Recruiting
- Registry status
- 5,000
- Enrollment target
- 1
- Study location
NCT06635668: Recruiting study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, sponsored by Sanford Health.
NCT06635668 is a study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury that is actively recruiting participants, run by Sanford Health. The registered enrollment target is 5,000 participants, above the 115-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (4248% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06635668, a study of Anterior Cruciate Ligament Injuries and Musculoskeletal Injury, is actively recruiting participants, sponsored by Sanford Health.
- RECRUITING
- Registry status
- 5,000 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a prospective, observational cohort study aimed at establishing a database of normative biomechanics for healthy athletes and surveying these athletes for one year following baseline testing for the occurrence of new musculoskeletal injuries, with a particular emphasis on ACL injuries.
Primary Outcome
The primary outcome measure will assess the incidence of ACL injuries among participants. This metric will be determined by responses to a follow-up survey administered at 6 and 12 months post-injury risk screen. Participants will be asked whether they sustained an injury that prevented them from participating in their sport or activity for 10 or more consecutive days. The measure will capture any new ACL injuries occurring within the specified follow-up period.
Conditions Studied
Study Locations (1)
North Dakota
- Sanford Health - Fargo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5,000 participants |
| Start Date | 2022-07-19 |
| Est. Completion | 2033-07-01 |
What NCT06635668 shows while recruiting
NCT06635668 is an observational study that tracks outcomes without assigning an intervention. Its 5,000 participants enrollment target places it among the larger protocols in the corpus, above the 115-participant average among 24 other Anterior Cruciate Ligament Injuries trials with a reported enrollment target (4248% higher).
The record links to 3 conditions, with Anterior Cruciate Ligament Injuries appearing as the primary indexed condition, and to 0 interventions.
NCT06635668 reports a single indexed study location in North Dakota.
Frequently Asked Questions
What is clinical trial NCT06635668 about?
NCT06635668 is a clinical study titled "Baseline ACL Injury Risk Screening and Normative Data". This is a prospective, observational cohort study aimed at establishing a database of normative biomechanics for healthy athletes and surveying these athletes for one year following baseline testing for the occurrence of new musculoskeletal injuries, with a particular emphasis on ACL injuries.
What is the current status of trial NCT06635668?
This trial is currently recruiting. The enrollment target is 5,000 participants. The study started on 2022-07-19. Estimated completion is 2033-07-01.
What conditions does trial NCT06635668 study?
This clinical trial studies the following conditions: Anterior Cruciate Ligament Injuries, Musculoskeletal Injury, ACL Injury.
Who is sponsoring clinical trial NCT06635668?
This trial is sponsored by Sanford Health, which has 34 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06635668 being conducted?
This trial has 1 study location across North Dakota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Anterior Cruciate Ligament Injuries
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06635668's enrollment target sits among peer trials
5,000 1st of 24 higher than 24 of 24 other Anterior Cruciate Ligament Injuries trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Anterior Cruciate Ligament Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
IPACK on Early Pain Scores After ACL Reconstruction
RECRUITING · Phase 4
-
Anterior Cruciate Ligament Recovery With Virtual Psychological Intervention
RECRUITING · NA
-
Steps Towards Osteoarthritis Prevention
RECRUITING · NA
-
Gait Rehabilitation to Treat FastOA
RECRUITING · NA
-
Dynamic Muscular Electrical Stimulation Following Anterior Cruciate Ligament Reconstruction in Military Academy Cadets
RECRUITING · NA
-
PRP in ACLR to Prevent PTOA
RECRUITING · Phase 3
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00060541 · 5,000 participants
Evaluation and Treatment of Neurosurgical Disorders
- NCT00575081 · 5,000 participants
Physiological Brain Atlas Development
- NCT00736749 · 5,000 participants
Long-Term Follow-Up of Patients Who Have Participated in Children's Oncology Group Studies
- NCT00900198 · 5,000 participants
Collection of Tissue Samples for Cancer Research
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI